Reuters logo
BRIEF-DelMar Pharmaceuticals announces $10 million registered direct offering
September 20, 2017 / 7:42 PM / in a month

BRIEF-DelMar Pharmaceuticals announces $10 million registered direct offering

Sept 20 (Reuters) - DelMar Pharmaceuticals Inc:

* Announces $10 million registered direct offering priced at-the-market

* Entered into securities purchase agreements of an aggregate of 8 million shares of common stock at $1.25 per share​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below